BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-4.41%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.21B
AUM Growth
+$6.21B
(-11%)
Cap. Flow
-$226M
Cap. Flow
% of AUM
-3.64%
Top 10 Holdings %
Top 10 Hldgs %
40.63%
Holding
166
New
10
Increased
37
Reduced
80
Closed
12
Top Buys
| 1 |
Elevance Health
ELV
|
$31.1M |
| 2 |
UnitedHealth
UNH
|
$24.2M |
| 3 |
Cigna
CI
|
$21.5M |
| 4 |
Humana
HUM
|
$20.8M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$10.5M |
Top Sells
| 1 |
Medtronic
MDT
|
$60.3M |
| 2 |
Inspire Medical Systems
INSP
|
$56.9M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$32.8M |
| 4 |
Charles River Laboratories
CRL
|
$16.7M |
| 5 |
Thermo Fisher Scientific
TMO
|
$15M |
Sector Composition
| 1 | Healthcare | 99.13% |
| 2 | Industrials | 0.77% |
| 3 | Energy | 0.04% |
| 4 | Communication Services | 0.01% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Danaher
DHR
$143B
| $33.9M | 0.55% |
136,533
-47,176
| -26% | -$11.7M |
|
|
52
Thermo Fisher Scientific
TMO
$183B
| $33.6M | 0.54% |
66,468
-29,633
| -31% | -$15M |
|
53
AtriCure
ATRC
$1.73B
| $32.7M | 0.53% |
747,560
-1,053
| -0.1% | -$46.1K |
|
54
Zimmer Biomet
ZBH
$20.8B
| $32M | 0.52% |
284,888
+53
| +0% | +$5.95K |
|
55
BioMarin Pharmaceuticals
BMRN
$11.3B
| $31M | 0.5% |
349,888
-10,716
| -3% | -$948K |
|
56
Centene
CNC
$14.8B
| $30.6M | 0.49% |
444,043
+151,516
| +52% | +$10.4M |
|
57
HUTCHMED
HCM
$2.62B
| $30.6M | 0.49% |
1,802,963
-2,620
| -0.1% | -$44.4K |
|
58
IQVIA
IQV
$31.4B
| $30.5M | 0.49% |
155,220
-6,900
| -4% | -$1.36M |
|
59
Globus Medical
GMED
$7.94B
| $30.3M | 0.49% |
609,615
-38,030
| -6% | -$1.89M |
|
|
60
Apellis Pharmaceuticals
APLS
$3.51B
| $30.2M | 0.49% |
793,841
+275,346
| +53% | +$10.5M |
|
61
Merck
MRK
$210B
| $30.1M | 0.48% |
291,896
-14,798
| -5% | -$1.52M |
|
62
Transmedics
TMDX
$3.65B
| $29.4M | 0.47% |
536,737
-75,876
| -12% | -$4.15M |
|
63
Sarepta Therapeutics
SRPT
$1.98B
| $29.3M | 0.47% |
241,752
+41,532
| +21% | +$5.03M |
|
64
Procept Biorobotics
PRCT
$2.11B
| $29.1M | 0.47% |
888,296
+146,779
| +20% | +$4.82M |
|
65
CareDx
CDNA
$678M
| $27.6M | 0.44% |
3,940,798
+224,321
| +6% | +$1.57M |
|
66
Cooper Companies
COO
$13.3B
| $27.5M | 0.44% |
86,567
| – | – |
|
67
Outset Medical
OM
$245M
| $26.2M | 0.42% |
2,408,430
-717,456
| -23% | -$7.81M |
|
68
Wave Life Sciences
WVE
$1.27B
| $25.8M | 0.42% |
4,494,458
| – | – |
|
69
ESSA Pharma
EPIX
$11.2M
| $24.4M | 0.39% |
7,898,583
| – | – |
|
70
Privia Health
PRVA
$2.84B
| $24.3M | 0.39% |
1,055,178
-67,466
| -6% | -$1.55M |
|
71
Black Diamond Therapeutics
BDTX
$164M
| $23.3M | 0.38% |
8,135,839
| – | – |
|
|
SILK
72
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $21.4M | 0.35% |
1,430,562
+73,799
| +5% | +$1.11M |
|
73
Castle Biosciences
CSTL
$673M
| $20.7M | 0.33% |
1,228,031
+103,988
| +9% | +$1.76M |
|
74
Hologic
HOLX
$14.7B
| $20.1M | 0.32% |
290,136
| – | – |
|
75
Legend Biotech
LEGN
$6.64B
| $18.7M | 0.3% |
278,154
+2,400
| +0.9% | +$161K |
|